Quick Answer
Zentalis Pharmaceuticals, Inc. reported Net Income of -$137.06 million for fiscal year 2025.
Zentalis Pharmaceuticals, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$137.06M | +17.4% |
| 2024 | -$165.84M | +43.2% |
| 2023 | -$292.19M | -23.4% |
| 2022 | -$236.81M | -49.2% |
| 2021 | -$158.72M | -34.7% |
| 2020 | -$117.84M | -158.1% |
| 2019 | -$45.66M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$26.69M | +33.5% | +0.7% |
| June 30, 2025 | -$26.87M | +69.6% | +44.3% |
| March 31, 2025 | -$48.28M | -579.5% | -20.2% |
| September 30, 2024 | -$40.16M | +27.7% | +54.5% |
| June 30, 2024 | -$88.28M | +21.6% | -976.8% |
| March 31, 2024 | $10.07M | +115.9% | +118.1% |
| September 30, 2023 | -$55.53M | -2.1% | +50.7% |
| June 30, 2023 | -$112.53M | -64.6% | -78.0% |
- Zentalis Pharmaceuticals, Inc. showed an increase of +17.4% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, Zentalis Pharmaceuticals, Inc.’s net income has declined by 200.2% (from -$45.66 million to -$137.06 million).
- The most recent figure is from Zentalis Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: